Solanbridge Group Announces Reseller
Agreement With Vega Biofuels
SLNX to market Biochar in
Canada, Jamaica, and South Central Asia
Houston, TX - December 4, 2014 - InvestorsHub NewsWire
- Solanbridge Group Inc (OTC:
SLNX) is pleased to announce that it has signed a Reseller
Agreement with Georgia-based Vega BioFuels, Inc (OTC:
VGPR) where Solanbridge has the opportunity to market Vega’s
Biochar product to its clients worldwide.
Vega’s Biochar product is a highly absorbent specially designed
charcoal-type product that among other things can be used as a soil
enhancement for the agricultural industry to significantly increase
crop yields. The Company’s Biochar offers a powerfully simple
solution to some of today’s most urgent environmental
concerns. The production of Biochar for carbon sequestration
in the soil is a carbon-negative process.
Charles R. Shirley, CEO of Solanbridge, stated, “We are are
excited to be working with Vega and selling their Biochar product
in Canada, Jamaica, and South Central Asia. We believe the
product will be a perfect fit for the medical marijuana markets we
are currently pursuing. BioChar will complement the
cultivation processes that they already have in place. We
also find the BioChar product to be a perfect complement to
Solanbridge’s current business plan.”
Michael K. Molen, Chairman/CEO of Vega Biofuels, Inc. stated,
“We are happy to announce the Agreement with Solanbridge.
This deal will significantly increase our marketing efforts for
Biochar. With the acquisitions Solanbridge has made recently
and their plans for future expansion, we feel they can have a
significant impact on our bottom line by reaching markets that we
are not currently marketing to.”
About Solanbridge Group Inc
Solanbridge Group Inc, based in The Woodlands, Texas, is a
diversified holding company looking to expand into the medical
marijuana industry by developing commercial grower’s licenses in
Eastern Canadian medical marijuana jurisdictions, with the
partnership of First Nations and developing CBD-infused products in
Colorado and Nevada. Solanbridge is also pursuing other
acquisitions in the growing medical marijuana field and
partnerships with agribusiness entities.
This release includes "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
This presentation contains forward-looking statements that involve
substantial risks and uncertainties. You can identify
forward-looking statements by words such as anticipate, believe,
could, estimate, expect, intend, may, plan, should, will, would or
similar words. You should consider these statements carefully
because they discuss our plans, targets, strategies, prospects and
expectations concerning our business, operating results, financial
condition and other similar matters. We believe that it is
important to communicate our future expectations to our investors.
There may be events in the future, however, that we are not able to
predict accurately or control. Our actual results may differ
materially from the expectations we describe in our forward looking
statements. Factors or events that could cause our actual results
to materially differ may emerge from time to time, and it is not
possible for us to accurately predict all of them. Before you
invest in our common stock, you should be aware that the occurrence
of any such event could have a material adverse effect on our
business, results of operation and financial position. Any
forward-looking statement made by us in this presentation speaks
only as of the date on which we make it. We undertake no obligation
to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
required by law.
Contact:
Charles R. Shirley
Solanbridge Group Inc
charles@solanbridgegroup.com
832.225.1372